COMMUNIQUÉS West-GlobeNewswire

Aptose Biosciences Establishes New At-the-Market Facility

28/03/2018 - 14:00

SAN DIEGO and TORONTO, March 28, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO ) (TSX: APS ), a clinical-stage company developing highly differentiated therapeutics that [...]

Albireo to Present Clinical Data on A4250 at The International Liver Congress™ 2018

28/03/2018 - 14:00

BOSTON, March 28, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that new data from its [...]

Actinium Pharmaceuticals Announces Collaborative Research Partnership with Astellas Leveraging Actinium’s AWE Platform Technology

28/03/2018 - 14:00

- Collaborative research agreement will utilize Actinium’s AWE Technology Platform to generate Actinium Radio-Conjugates on selected Astellas targeting agents - Actinium to perform preclinical validation studies on [...]

FDA Grants Orphan Drug Designation to Cynata’s Lead Cymerus™ MSC Product, CYP-001

28/03/2018 - 14:00

MELBOURNE, Australia, March 28, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company Cynata Therapeutics Limited (ASX:CYP) is pleased to announce that the United States Food and Drug [...]

BIOPHYTIS: 2017 Full Year Results

28/03/2018 - 14:00

Launch and progress in the SARA-OBS observational clinical study in the United States, Belgium, France, and Italy; Agencies’ authorizations of SARA-INT phase 2b interventional clinical study in the United States and [...]

3D Signatures Collaborates with MDxHealth to Evaluate Telo-PC™ Test in Prostate Cancer

28/03/2018 - 14:00

TORONTO, March 28, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V: DXD ) (OTCQB:TDSGF) (FSE:3D0) (the “Company” or " 3DS "), a personalized medicine company with a proprietary software platform (TeloView TM ) based [...]

Glycotope Selects CrownBio as a Preclinical Development Partner to Advance Their Immunotherapeutic Pipeline

28/03/2018 - 14:00

SAN DIEGO, March 28, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]

Avenue Therapeutics Receives Notices of Allowance for Patent Applications Covering Methods of Administration for Intravenous Tramadol

28/03/2018 - 14:00

NEW YORK, March 28, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI ) (“Avenue”), a company focused on the development and commercialization of intravenous (IV) tramadol, today announced receipt of [...]

Inovalon Announces New Post Acute Care Services Agreement with Tenet Healthcare

28/03/2018 - 13:55

BOWIE, Md., March 28, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV ), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based [...]

Precipio Files Patent for Non-Invasive Cell Capture Device For Gynecological Cancer Detection

28/03/2018 - 13:37

In collaboration with Yale, feminine panty liner designed to remove obstacles to early detection NEW HAVEN, Conn., March 28, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO ), [...]

MacroGenics Announces Pricing of Public Offering of Common Stock

28/03/2018 - 13:30

ROCKVILLE, MD, March 28, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]

Mersana Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Business Updates

28/03/2018 - 13:30

Enrollment on Track for Phase 1 Trial of XMT-1522 Patients with Advanced Tumors Expressing HER2 Progressing Phase 1 Trial of XMT-1536, First-in-Class Dolaflexin ® Antibody Drug Conjugate Targeting NaPi2b Appointed David [...]

ICC Labs Signs Term Sheet to Acquire Equity Stake in Strategic Partner and Enter the European Market

28/03/2018 - 13:30

Highlights of proposed transaction, include ICC gaining: Access to five important European markets: Germany, United Kingdom, Spain, Italy and France. Use of an established multi-channel distribution network for CBD [...]

Immunovaccine Announces Initiation of Patient Dosing in Investigator-Sponsored Phase 2 Clinical Trial of Its Lead Candidate DPX-Survivac Used in Combination with Pembrolizumab in Patients with DLBCL

28/03/2018 - 13:05

HALIFAX, Nova Scotia, March 28, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that the first patient has been treated in a Phase 2 Study [...]

Nexstim Plc: Decisions of the Board of Directors regarding Board Committees, approval of a financing arrangement and issuance of shares under the restricted share unit plan

28/03/2018 - 13:01

Company announcement, Helsinki, 28 March 2018, at 2 PM Nexstim Plc: Decisions of the Board of Directors regarding Board Committees, approval of a financing arrangement and issuance of shares under the restricted share [...]

Summit Therapeutics Selected for Emerging Science Presentation at the 2018 AAN Annual Meeting

28/03/2018 - 13:01

Summit Therapeutics plc ("Summit", or the "Company") Summit Therapeutics Selected for Emerging Science Presentation at the 2018 American Academy of Neurology Annual Meeting Oxford, UK, and Cambridge, MA, US, 28 March [...]

Edge Therapeutics Provides Update following Interim Analysis of Phase 3 NEWTON 2 Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage

28/03/2018 - 13:00

Study Unlikely To Achieve Primary Efficacy Endpoint; DMC Recommends Discontinuation of Study No Unexpected Safety Findings Edge To Reduce Costs and Evaluate Next Steps Edge To Host Conference Call on Wednesday, March 28 [...]

Cesca Therapeutics Inc. Announces Two Abstracts Accepted for Poster Presentation at the International Society for Cellular Therapy (ISCT) 2018 Annual Meeting

28/03/2018 - 13:00

RANCHO CORDOVA, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ: KOOL ) today announced that two late-breaking abstracts involving the use of Cesca’s X-Series™ technologies for cell [...]

Aileron Therapeutics Announces Expansion of Scientific Advisory Board

28/03/2018 - 13:00

CAMBRIDGE, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ: ALRN ), the clinical-stage leader in the field of stapled peptide therapeutics for cancers and other diseases, today announced that [...]